David L. F. Gray - 27 Feb 2023 Form 4 Insider Report for Vigil Neuroscience, Inc. (VIGL)

Role
Chief Science Officer
Signature
/s/ Christopher Verni, Attorney-in-Fact
Issuer symbol
VIGL
Transactions as of
27 Feb 2023
Net transactions value
$0
Form type
4
Filing time
27 Feb 2023, 18:04:01 UTC
Next filing
01 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIGL Stock Option Grant (Right to Buy) Award $0 +267,000 $0.000000 267,000 27 Feb 2023 Common Stock 267,000 $12.09 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option award was issued pursuant to the Issuer's 2021 Stock Option and Incentive Plan and shall vest as follows: 25% of the shares shall be vested on February 27, 2024 and 1/36th of the remaining shares shall vest on each monthly anniversary thereafter.